Literature DB >> 25481853

Abuse liability of the dietary supplement dimethylamylamine.

Sean B Dolan1, Michael B Gatch2.   

Abstract

BACKGROUND: Dimethylamylamine (DMAA) is a component of many dietary supplements and has recently been associated with numerous adverse effects, prompting the US military and World Anti-Doping Agency to ban its use as a supplement. The current study aimed to elucidate the abuse liability profile of DMAA.
METHODS: Dose-response studies of DMAA were performed with Swiss-Webster mice in locomotor and conditioned place-preference assays. The discriminative stimulus effects of DMAA were investigated in Sprague-Dawley rats trained to discriminate either cocaine or methamphetamine from saline.
RESULTS: DMAA produced dose-dependent locomotor depression and fully substituted for cocaine and partially substituted for methamphetamine. In the conditioned place-preference assay, DMAA produced an inverted-U-shaped dose-response curve, with intermediate doses producing significant place preference.
CONCLUSIONS: The cocaine- and methamphetamine-like discriminative stimulus effects and the conditioned place preference produced by DMAA suggest that is has potential for abuse. These findings in combination with reports of substantial adverse effects of DMAA in humans suggest that control of DMAA may warrant further consideration.
Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Abuse liability; Conditioned place preference; Dimethylamylamine; Drug discrimination; Locomotor activity

Mesh:

Substances:

Year:  2014        PMID: 25481853      PMCID: PMC4272877          DOI: 10.1016/j.drugalcdep.2014.11.006

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.492


  29 in total

1.  Comparison of pressor action of alicyclic derivatives of aliphatic amines.

Authors:  E E SWANSON; K K CHEN
Journal:  J Pharmacol Exp Ther       Date:  1948-08       Impact factor: 4.030

2.  Comparison of pressor action of aliphatic amines.

Authors:  E E SWANSON; K K CHEN
Journal:  J Pharmacol Exp Ther       Date:  1946-09       Impact factor: 4.030

3.  Noradrenergic modulation of the discriminative-stimulus effects of methamphetamine in rats.

Authors:  P Munzar; S R Goldberg
Journal:  Psychopharmacology (Berl)       Date:  1999-04       Impact factor: 4.530

4.  Dopamine transporter binding without cocaine-like behavioral effects: synthesis and evaluation of benztropine analogs alone and in combination with cocaine in rodents.

Authors:  J L Katz; G E Agoston; K L Alling; R H Kline; M J Forster; W L Woolverton; T A Kopajtic; A H Newman
Journal:  Psychopharmacology (Berl)       Date:  2001-04       Impact factor: 4.530

5.  Effect of clonidine, amphetamine, and their combinations on the locomotor activity of CD-1 and C57BL/6 mice.

Authors:  J Hano; J Vetulani; M Sansone; A Oliverio
Journal:  Pharmacol Biochem Behav       Date:  1978-12       Impact factor: 3.533

Review 6.  A translational pharmacology approach to understanding the predictive value of abuse potential assessments.

Authors:  David B Horton; David M Potter; Andy N Mead
Journal:  Behav Pharmacol       Date:  2013-09       Impact factor: 2.293

7.  Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for cocaine addiction.

Authors:  F Ivy Carroll; Bruce E Blough; Philip Abraham; Andrew C Mills; J Ashley Holleman; Scott A Wolckenhauer; Ann M Decker; Antonio Landavazo; K Timothy McElroy; Hernán A Navarro; Michael B Gatch; Michael J Forster
Journal:  J Med Chem       Date:  2009-11-12       Impact factor: 7.446

8.  Case reports: Death of active duty soldiers following ingestion of dietary supplements containing 1,3-dimethylamylamine (DMAA).

Authors:  Michael J Eliason; Amy Eichner; Anthony Cancio; Lori Bestervelt; Bruce D Adams; Patricia A Deuster
Journal:  Mil Med       Date:  2012-12       Impact factor: 1.437

9.  One-way generalization of clonidine to the discriminative stimulus produced by cocaine.

Authors:  D M Wood; H Lal; S Yaden; M W Emmett-Oglesby
Journal:  Pharmacol Biochem Behav       Date:  1985-10       Impact factor: 3.533

10.  Evidence for the Presence of 1,3-Dimethylamylamine (1,3-DMAA) in Geranium Plant Materials.

Authors:  Thomas D Gauthier
Journal:  Anal Chem Insights       Date:  2013-06-06
View more
  6 in total

1.  Locomotor activity and discriminative stimulus effects of five novel synthetic cathinone analogs in mice and rats.

Authors:  Michael B Gatch; Sean B Dolan; Michael J Forster
Journal:  Drug Alcohol Depend       Date:  2019-04-06       Impact factor: 4.492

2.  Discriminative stimulus and locomotor effects of para-substituted and benzofuran analogs of amphetamine.

Authors:  Sean B Dolan; Michael J Forster; Michael B Gatch
Journal:  Drug Alcohol Depend       Date:  2017-08-24       Impact factor: 4.492

3.  Locomotor, discriminative stimulus, and place conditioning effects of MDAI in rodents.

Authors:  Michael B Gatch; Sean B Dolan; Michael J Forster
Journal:  Behav Pharmacol       Date:  2016-09       Impact factor: 2.293

4.  Effects of controlled doses of Oxyelite Pro on physical performance in rats.

Authors:  Paulo Vinicios Camuzi Zovico; Victor Magalhães Curty; Marcos André Soares Leal; Eduardo Frizzera Meira; Daniel Ventura Dias; Lívia Carla de Melo Rodrigues; Silvana Dos Santos Meyrelles; Edilamar Menezes De Oliveira; Paula Frizera Vassallo; Valério Garrone Barauna
Journal:  Nutr Metab (Lond)       Date:  2016-12-06       Impact factor: 4.169

Review 5.  Sympathomimetic amine compounds and hepatotoxicity: Not all are alike-Key distinctions noted in a short review.

Authors:  Cyril Willson
Journal:  Toxicol Rep       Date:  2018-12-01

6.  Surveillance of the armed forces as a sentinel system for detecting adverse effects of dietary supplements in the general population.

Authors:  Harris R Lieberman; Krista G Austin; Emily K Farina
Journal:  Public Health Nutr       Date:  2017-11-20       Impact factor: 4.022

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.